Delivery Order SPE2DB22D1017-SPE2DB25FF2WW

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $8,501.74 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Repatha 140 mg/mL SureClick medication, a specialty cardiovascular drug. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,016.82 firm fixed-price award is for the supply of Repatha 140 mg/mL SureClick medication, which is used to treat cardiovascular conditions. The order is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,050.01, is for the procurement of Repatha 140 mg/mL SureClick, a specialty medication used for cardiovascular health. The delivery order was issued under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,051.98 firm-fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick medication. The contract has an ultimate completion date of January 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal delivery order award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,996.14, is for the supply of Repatha 140 mg/mL SureClick, a specialty medication used for cardiovascular health. The contract has an ultimate completion date of October 22, 2024, and is a firm-fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,768.80 firm fixed-price contract is for the delivery of Repatha 140 mg/mL SureClick® medication. The contract does not have a set-aside designation, indicating open competition. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $8,894.64. The contract is for the supply of Repatha 140 mg/mL SureClick, a specialty medication used to treat cardiovascular conditions. The award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999, which covers a broad...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,554.76 firm-fixed-price contract covers the supply of Repatha 140 mg/mL SureClick, a specialty medication for cardiovascular health. The contract has an ultimate completion date of September 18, 2024 and was awarded on September 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,368.56 contract is for the supply of Repatha 140 mg/mL SureClick injectors, a specialty cardiovascular medication. The contract has an ultimate completion date of July 5, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,103.96, is for the supply of Repatha 140 mg/mL SureClick medication. It is a firm-fixed-price contract with a period of performance through January 6, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF2WW
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,737.22 contract is for the supply of Repatha 140 mg/ml SureClick, a specialty cardiovascular medication. The delivery order falls under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a firm fixed price pricing type and an ultimate completion date of January 13, 2025. No set-aside designation was used for this award.

Generated 4/11/25, 11:27 AM